Advertisement
Screener

PRECIPIO, INC. (PRPO) Stock Issued During Period, Value, Issued for Services

3.0 / 5 stars · 43/71 Roast Me

PRECIPIO, INC. Stock Issued During Period, Value, Issued for Services

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • PRECIPIO, INC. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $34.00K, a 49.25% decline year-over-year.
  • PRECIPIO, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $53.00K, a 18.46% decline year-over-year.
  • PRECIPIO, INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $48.00K, a 17.24% decline year-over-year.
  • PRECIPIO, INC. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $67.00K, a 73.31% decline year-over-year.
  • PRECIPIO, INC. stock issued during period, value, issued for services for fiscal 2024 was $386.00K, a 118.08% increase from fiscal 2023.
  • PRECIPIO, INC. stock issued during period, value, issued for services for fiscal 2023 was $177.00K.
  • PRECIPIO, INC. stock issued during period, value, issued for services for fiscal 2021 was $150.00K.
  • PRECIPIO, INC. stock issued during period, value, issued for services for fiscal 2018 was $39.00K, a 98.22% decline from fiscal 2017.
Period endStock Issued During Period, Value, Issued for Services 3 monthStock Issued During Period, Value, Issued for Services 12 month
2026-06-30$34.00K
10-Q · filed 2026-08-14
2026-03-31$53.00K
10-Q · filed 2026-05-14
2025-09-30$48.00K
10-Q · filed 2025-11-14
$257.00K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$67.00K
10-Q · filed 2026-08-14
$267.00K
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$65.00K
10-Q · filed 2026-05-14
$451.00K
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$77.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$386.00K
10-K · filed 2025-03-27
2024-09-30$58.00K
10-Q · filed 2025-11-14
2024-06-30$251.00K
10-Q · filed 2025-08-13
2023-12-31$177.00K
10-K · filed 2025-03-27
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$150.00K
10-K · filed 2023-03-30
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
2021-03-31$150.00K
10-Q · filed 2022-05-11
2018-12-31$39.00K
10-K · filed 2020-03-27
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-16
$2.19M
10-K · filed 2019-04-16
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20
2016-12-31$89.00K
10-K · filed 2017-04-13
2015-12-31$0.00
10-K · filed 2017-04-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15